For citations:
Gantsev K.Sh., Khmelevskiy A.A. Combined Use of Bevacizumab + Interferon A-2 α in the Treatement of Patients with Disseminated Kidney Cancer in Comparison with an Active Monitoring Group. Creative surgery and oncology. 2018;8(4):263-267. (In Russ.) https://doi.org/10.24060/2076-3093-2018-8-4-263-267
Views PDF (Rus): 361
Email this article 